New insight into the treatment of advanced differentiated thyroid cancer

Arash Safavi, Aparna Vijayasekaran, Marlon A. Guerrero

Research output: Contribution to journalReview articlepeer-review

7 Scopus citations


The vast majority of patients with differentiated thyroid cancer (DTC) are treated successfully with surgery and radioactive iodine ablation, yet the treatment of advanced cases is frustrating and largely ineffective. Systemic treatment with conventional cytotoxic chemotherapy is basically ineffective in most patients with advanced DTC. However, a better understanding of the genetics and biologic basis of thyroid cancers has generated opportunities for innovative therapeutic modalities, resulting in several clinical trials. We aim to delineate the latest knowledge regarding the biologic characteristics of DTC and to describe the available data related to novel targeted therapies that have demonstrated clinical effectiveness.

Original languageEnglish (US)
Article number437569
JournalJournal of Thyroid Research
StatePublished - 2012

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism


Dive into the research topics of 'New insight into the treatment of advanced differentiated thyroid cancer'. Together they form a unique fingerprint.

Cite this